{
  "symbol": "INM",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "cannabinoid-based therapies", "small market cap", "clinical stage developments"],
    "riskScore": 8,
    "reason": "InMed Pharmaceuticals operates in the biotechnology sector with a focus on cannabinoid-based therapies, making it prone to social media hype and speculative trading. Its small market cap and clinical stage developments further increase its susceptibility to volatility."
  }
}